A Hypofractionated Radiotherapy Schedule with a Simultaneous Integrated Boost for Breast Cancer: Outcomes including Late Toxicity and Health Quality

Introduction: This study aimed to evaluate the long-term adverse effects on the physical appearance and overall well-being of breast cancer patients who receive hypofractionated radiotherapy as whole breast and simultaneous integrated boost (SIB) treatment, utilizing intensive modulated radiotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Akgun, Zuleyha, Cakir, Aydin, Sağlam, Esra, Demirel, Sertac, Igci, Abdullah, Keskin, Serkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144295/
https://www.ncbi.nlm.nih.gov/pubmed/37109633
http://dx.doi.org/10.3390/medicina59040675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144295/
https://www.ncbi.nlm.nih.gov/pubmed/37109633
http://dx.doi.org/10.3390/medicina59040675

Ejemplares similares